This webinar aims to inform and answer participants questions on funding announcement RFA-NS-21-010. The goal of this announcement is to accelerate the optimization and development of promising small molecule and biologic hits/leads to Phase I clinical trials and readiness for the Early Phase Pain Investigation Clinical Network (EPPIC-Net) or other Phase II clinical studies.
